(Reuters) -Health tech firm Medtronic ( MDT ) beat Wall Street estimates for quarterly profit and revenue on Thursday, as a post-pandemic pickup in surgical volumes at hospitals boosted demand for its medical devices.

Medtronic ( MDT ) joins medical device makers such as Abbott Laboratories and Boston Scientific that have also benefited from soaring demand for non-urgent surgeries.

The company's revenue for the quarter rose 0.5% to $8.59 billion, beating analysts' average estimate of $8.44 billion, according to LSEG data.

It posted adjusted profit of $1.46 per share for the fourth quarter, compared with analysts' estimate of $1.45 per share.